Nine polymorphisms in in the CYP19 gene were examined in 207 cases of AD, 23 cases of mild cognitive impairments (MCI), and 233 controls from the OPTIMA cohort that included men and women. The gene discussed is CYP19A1; the disease is Alzheimer disease.